Abstract 3464: CRISPR-mediated inactivation of ATRX and DAXX in pancreatic neuroendocrine tumor cell lines

MLA

Jacqueline A. Brosnan-Cashman, et al. “Abstract 3464: CRISPR-Mediated Inactivation of ATRX and DAXX in Pancreatic Neuroendocrine Tumor Cell Lines.” Cancer Research, vol. 77, July 2017, p. 3464. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f6aed62256fbb59e5d95ab11f3fda291&authtype=sso&custid=ns315887.

APA

Jacqueline A. Brosnan-Cashman, Alan K. Meeker, Mindy K. Graham, Anthony J. Rizzo, & Christopher M. Heaphy. (2017). Abstract 3464: CRISPR-mediated inactivation of ATRX and DAXX in pancreatic neuroendocrine tumor cell lines. Cancer Research, 77, 3464.

Chicago

Jacqueline A. Brosnan-Cashman, Alan K. Meeker, Mindy K. Graham, Anthony J. Rizzo, and Christopher M. Heaphy. 2017. “Abstract 3464: CRISPR-Mediated Inactivation of ATRX and DAXX in Pancreatic Neuroendocrine Tumor Cell Lines.” Cancer Research 77 (July): 3464. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f6aed62256fbb59e5d95ab11f3fda291&authtype=sso&custid=ns315887.